Medicover AB (publ)'s latest marketcap:
As of 04/30/2026, Medicover AB (publ)'s market capitalization has reached $3.42 B. According to our data, Medicover AB (publ) is the 5010th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.42 B |
| Revenue (ttm) | 2.87 B |
| Net Income (ttm) | 94.02 M |
| Shares Out | 150.98 M |
| EPS (ttm) | 0.62 |
| Forward PE | 27.10 |
| Ex-Dividend Date | 04/30/2026 |
| Earnings Date | 04/29/2026 |
Medicover AB (publ)'s yearly market capitalization.
| Date | Market Cap(kr) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 06/01/2026 | kr31.23 B | $3.39 B | -6.19% | n/a |
| 12/30/2025 | kr33.29 B | $3.52 B | 15.49% | 3860 |
| 12/30/2024 | kr28.83 B | $2.59 B | 28.33% | 4802 |
| 12/29/2023 | kr22.46 B | $2.21 B | 7.84% | 5273 |
| 12/30/2022 | kr20.83 B | $1.99 B | -62.3% | 5393 |
| 12/30/2021 | kr55.25 B | $6.08 B | 127.1% | 2751 |
| 12/30/2020 | kr24.33 B | $0 | 68% | 4190 |
| 12/30/2019 | kr14.48 B | $1.54 B | 48.16% | 5339 |
| 12/28/2018 | kr9.77 B | $1.1 B | 16.35% | 5825 |
| 12/29/2017 | kr8.4 B | $1.02 B | 7033 |
Company Profile
About Medicover AB (publ)
Medicover AB (publ) is a leading provider of healthcare and diagnostic services, operating in Poland, India, Romania, Sweden, and internationally.
Healthcare Services
The company offers a comprehensive range of healthcare solutions, including:
- Outpatient and inpatient care
- Dental services
- Hospital care
- Preventive care
- Wellness services and non-medical offerings (sports memberships, benefit cards, optics)
Diagnostic Services
Medicover provides advanced laboratory testing across all major clinical pathology areas, from routine to specialized tests. Key diagnostic services include:
- Allergy and autoimmune diagnostics
- Bacteriology and parasitology
- Biochemistry and immunochemistry
- Blood group diagnostics/transfusion medicine
- Tumour markers and clinical chemistry
- Cytology, haematology, and histopathology
- Human genetics and molecular biology
- Infectious disease testing
- Pharmacology/toxicology
Customer Base
The company serves a diverse clientele, including:
- Corporate clients
- Individual patients
- Public payers
Founded: 1995
Headquarters: Stockholm, Sweden
Frequently Asked Questions
-
What is Medicover AB (publ)'s (STO-MCOV.B) current market cap?As of 04/30/2026, Medicover AB (publ) (including the parent company, if applicable) has an estimated market capitalization of $3.42 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Medicover AB (publ) (STO-MCOV.B) rank globally by market cap?Medicover AB (publ) global market capitalization ranking is approximately 5010 as of 04/30/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.